Global Irritable Bowel Syndrome (IBS) Therapeutics Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 11098

IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.

The global Irritable Bowel Syndrome (IBS) Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Irritable Bowel Syndrome (IBS) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome (IBS) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Valeant Pharmaceuticals International
Ardelyx
Astellas Pharma
Novartis
GlaxoSmithKline
Ironwood Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Blautix (Strain)
Bekinda (IBS-D)
SYN-010
Tenapanor

Segment by Application
Hospital
Research

Table of Contents

Executive Summary
1 Irritable Bowel Syndrome (IBS) Therapeutics Market Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome (IBS) Therapeutics
1.2 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Blautix (Strain)
1.2.3 Bekinda (IBS-D)
1.2.4 SYN-010
1.2.5 Tenapanor
1.3 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Application
1.3.1 Irritable Bowel Syndrome (IBS) Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Research
1.4 Global Irritable Bowel Syndrome (IBS) Therapeutics Market by Region
1.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size
1.5.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue (2014-2025)
1.5.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Production (2014-2025)

2 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Competition by Manufacturers
2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Production Sites, Area Served, Product Types
2.5 Irritable Bowel Syndrome (IBS) Therapeutics Market Competitive Situation and Trends
2.5.1 Irritable Bowel Syndrome (IBS) Therapeutics Market Concentration Rate
2.5.2 Irritable Bowel Syndrome (IBS) Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Regions
3.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Regions
3.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions (2014-2019)
3.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Irritable Bowel Syndrome (IBS) Therapeutics Production
3.4.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019)
3.4.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Irritable Bowel Syndrome (IBS) Therapeutics Production
3.5.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019)
3.5.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Irritable Bowel Syndrome (IBS) Therapeutics Production (2014-2019)
3.6.1 China Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019)
3.6.2 China Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Irritable Bowel Syndrome (IBS) Therapeutics Production (2014-2019)
3.7.1 Japan Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate (2014-2019)
3.7.2 Japan Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Regions
4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Regions
4.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Consumption (2014-2019)
4.3 Europe Irritable Bowel Syndrome (IBS) Therapeutics Consumption (2014-2019)
4.4 China Irritable Bowel Syndrome (IBS) Therapeutics Consumption (2014-2019)
4.5 Japan Irritable Bowel Syndrome (IBS) Therapeutics Consumption (2014-2019)

5 Global Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price Trend by Type
5.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Type (2014-2019)
5.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Type (2014-2019)
5.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Price by Type (2014-2019)
5.4 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Growth by Type (2014-2019)

6 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis by Applications
6.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Share by Application (2014-2019)
6.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Irritable Bowel Syndrome (IBS) Therapeutics Business
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.1.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.1.3 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Synergy Pharmaceuticals
7.2.1 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.2.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.2.3 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Sucampo Pharmaceuticals
7.3.1 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.3.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Valeant Pharmaceuticals International
7.4.1 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.4.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.4.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Ardelyx
7.5.1 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.5.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.5.3 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Astellas Pharma
7.6.1 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.6.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.6.3 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Novartis
7.7.1 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.7.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.7.3 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.8.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.8.3 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Ironwood Pharmaceuticals
7.9.1 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
7.9.2 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction, Application and Specification
7.9.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served

8 Irritable Bowel Syndrome (IBS) Therapeutics Manufacturing Cost Analysis
8.1 Irritable Bowel Syndrome (IBS) Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS) Therapeutics
8.4 Irritable Bowel Syndrome (IBS) Therapeutics Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Irritable Bowel Syndrome (IBS) Therapeutics Distributors List
9.3 Irritable Bowel Syndrome (IBS) Therapeutics Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Forecast
11.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue Forecast
11.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Forecast (2019-2025)
11.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Price and Trend Forecast (2019-2025)
11.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Forecast by Regions (2019-2025)
11.2.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue Forecast (2019-2025)
11.2.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue Forecast (2019-2025)
11.2.3 China Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue Forecast (2019-2025)
11.2.4 Japan Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue Forecast (2019-2025)
11.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Forecast by Regions (2019-2025)
11.3.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Consumption Forecast (2019-2025)
11.3.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Consumption Forecast (2019-2025)
11.3.3 China Irritable Bowel Syndrome (IBS) Therapeutics Consumption Forecast (2019-2025)
11.3.4 Japan Irritable Bowel Syndrome (IBS) Therapeutics Consumption Forecast (2019-2025)
11.4 Global Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer